Status:
COMPLETED
Using Smartphones to Enhance the Treatment of Childhood Anxiety
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Anxiety
Eligibility:
All Genders
9-14 years
Phase:
NA
Brief Summary
The primary goal of this research study is to develop an interactive smartphone app that could be used to increase the effectiveness of talk therapy such as cognitive behavioral therapy (CBT) for chil...
Detailed Description
Boys and girls between the ages of 9-14 who have anxiety and a parent or caregiver are being asked to participate in this study. Interested participants who contact the study will be asked to undergo ...
Eligibility Criteria
Inclusion
- Participants will be 40 children of either sex ages 9 years, 0 months to 14 years, 11 months with DSM-IV diagnosis of Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), and/or Social Phobia (SP) as identified by the Kiddie Schedule of Affective Disorders.
- The primary caregiver is defined as the person who has the most responsibility for taking care of the child. While this is typically the mother, it can be the father, an adoptive parent or other legal guardian. The primary caregiver must be a legal guardian of the child.
Exclusion
- Requires current ongoing treatment with psychoactive medications other than stimulants.
- Acutely suicidal or at risk for harm to self or others.
- Neuromuscular or neurological disorder.
- Reading level below 80 on the Wide Range Achievement Test-4 (WRAT-4)
- Medical illnesses or medications taken for an illness as determined by study physicians that would affect study adherence, and subject's emotional state.
- Current comorbid diagnosis of: primary major depressive disorder (MDD) (subjects who have primary GAD with co-morbid MDD that is secondary in terms of course and functional impact are not excluded), obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), conduct disorder, substance abuse or dependence, and ADHD combined type or predominantly hyperactive-impulsive type.
- Lifetime diagnosis of autism spectrum disorder, bipolar disorder, psychotic depression, schizophrenia, or schizoaffective disorder.
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2017
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02259036
Start Date
August 1 2014
End Date
May 31 2017
Last Update
November 16 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pittsburgh, Dept. of Psychology
Pittsburgh, Pennsylvania, United States, 15213